Marialaura Simonetto (@ml_simonetto) 's Twitter Profile
Marialaura Simonetto

@ml_simonetto

Neurology resident in NYC at Weill Cornell/NYPH, former Olympic swimmer, interested in stroke research and epidemiology

ID: 1215299088318636032

calendar_today09-01-2020 15:47:43

44 Tweet

304 Takipçi

266 Takip Edilen

Weill Cornell Neurology (@wcmcneurology) 's Twitter Profile Photo

Congratulations to this team led by our Alex Merkler for this important ESUS study in JAMA Neurology demonstrating rivaroxaban superiority to aspirin in recurrent #stroke or systemic embolism in left ventricular dysfunction. Hooman Kamel Weill Cornell Medicine

Manon Kappelhof (@manonkappelhof) 's Twitter Profile Photo

Prof. Diederik Dippel presented the results of the MR CLEAN MED trial. Clear conclusion: avoid both aspirin and heparin during EVT for acute ischemic stroke. A good example of the importance of interim analyses by a strong DSMB! European Stroke Org @Ellis_van_Etten #GSSW #MRCLEAN

Prof. Diederik Dippel presented the results of the MR CLEAN MED trial. Clear conclusion: avoid both aspirin and heparin during EVT for acute ischemic stroke. A good example of the importance of interim analyses by a strong DSMB! <a href="/ESOstroke/">European Stroke Org</a> @Ellis_van_Etten #GSSW #MRCLEAN
Weill Cornell Neurology (@wcmcneurology) 's Twitter Profile Photo

Congratulations to our resident and McGraw Fellow in #Neurology Research Virginia Gao for this recognition from American Academy of Neurology for her work in alpha-synuclein biochemical changes in the central & enteric nervous system in #Parkinsons disease! WCM Brain and Mind Research Institute Weill Cornell Medicine NewYork-Presbyterian

Congratulations to our resident and McGraw Fellow in #Neurology Research <a href="/virginia_gao/">Virginia Gao</a> for this recognition from <a href="/AANMember/">American Academy of Neurology</a> for her work in alpha-synuclein biochemical changes in the central &amp; enteric nervous system in #Parkinsons disease!
<a href="/WCM_BMRI/">WCM Brain and Mind Research Institute</a> <a href="/WeillCornell/">Weill Cornell Medicine</a> <a href="/nyphospital/">NewYork-Presbyterian</a>
Weill Cornell Neurology (@wcmcneurology) 's Twitter Profile Photo

Congratulations to our resident Marialaura Simonetto, recent grad Dr. Rutrick, faculty Dr. Navi & our great team on a national assessment of #cancer screening in #stroke survivors in JSCVD Scott Tagawa Hooman Kamel Neal S Parikh MD strokejournal.org/article/S1052-…

Neal S Parikh MD (@nealsparikhmd) 's Twitter Profile Photo

Hi, I promise, last push: *Please complete* survey on smoking cessation treatments after stroke/TIA. Stroke docs, neurohospitalists, neurologists who care for #stroke /TIA: survey.alchemer.com/s3/6668536/Pra… Hooman Kamel Aravind Ganesh Neurology: Clinical Practice Stroke AHA/ASA

Stroke AHA/ASA (@strokeaha_asa) 's Twitter Profile Photo

American Heart Association grieves the loss of Past President Ralph L. Sacco, M.D., M.S., FAHA, FAAN newsroom.heart.org/news/american-…

Santosh Murthy (@san_murthy) 's Twitter Profile Photo

More emerging data from Drs. Boe, Gaist, and colleagues supporting the heightened cardiovascular risk in ICH survivors. Enjoyed writing this invited commentary with Weill Cornell Neurology chief resident Marialaura Simonetto JAMA Network Open jamanetwork.com/journals/jaman…

Stroke AHA/ASA (@strokeaha_asa) 's Twitter Profile Photo

TIMELESS trial shows no benefit of TNK in the extended time window of 4.5-24 hours of LKW among patients with ICA/M1/M2 occlusion did not show benefit on the 90-day mRS without any signal of safety concerns. #ESOC2023

TIMELESS trial shows no benefit of TNK in the extended time window of 4.5-24 hours of LKW among patients with ICA/M1/M2 occlusion did not show benefit on the 90-day mRS without any signal of safety concerns. #ESOC2023
Seemant Chaturvedi (@chaturvedineuro) 's Twitter Profile Photo

ARCADIA shows no benefit with apixaban compared to aspirin in pts with ESUS and atrial cardiopathy. About 4% rate in both groups, no safety concerns. Where does this leave the ESUS concept? #ESOC2023 ⁦Hooman Kamel⁩ ⁦Mitchell Elkind

ARCADIA shows no benefit with apixaban compared to aspirin in pts with ESUS and atrial cardiopathy. About 4% rate in both groups, no safety concerns. Where does this leave the ESUS concept? #ESOC2023
⁦<a href="/hoomankamel/">Hooman Kamel</a>⁩ ⁦<a href="/MitchElkind/">Mitchell Elkind</a>⁩